Periodontitis: From microbial immune subversion to systemic inflammation

Nature Reviews Immunology

Volumn 15, Issue 1, 2015, Pages 30-44

  Hajishengallis, George ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALVEOLAR BONE; ANAEROBIC BACTERIUM; ASPIRATION PNEUMONIA; ATHEROMA; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE PREDISPOSITION; DYSBIOSIS; GINGIVA; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; MICROBIAL COMMUNITY; MOUTH FLORA; MOUTH INFECTION; NEUTROPHIL; NONHUMAN; PERIODONTAL LIGAMENT; PERIODONTITIS; PERIODONTIUM; PORPHYROMONAS GINGIVALIS; PREGNANCY OUTCOME; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATOID ARTHRITIS; ANIMAL; ANTIBIOSIS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; COMPLICATION; FEMALE; IMMUNITY; IMMUNOLOGY; MICROBIOLOGY; PREGNANCY; RESPIRATORY TRACT DISEASES; SYMBIOSIS;

ANIMALS; ANTIBIOSIS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; IMMUNITY; PERIODONTITIS; PREGNANCY; PREGNANCY OUTCOME; RESPIRATORY TRACT DISEASES; SYMBIOSIS;

EID: 84971323731     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3785     Document Type: Review

References (171)

1. Pihlstrom, B. L., Michalowicz, B. S. & Johnson, N. W. Periodontal diseases. Lancet 366, 1809-1820 (2005).
2. Adler, C. J. et al. Sequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and Industrial revolutions. Nature Genet. 45, 450-455 (2013).
3. Eke, P. I., Dye, B. A., Wei, L., Thornton-Evans, G. O. & Genco, R. J. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J. Dent. Res. 91, 914-920 (2012).
4. Genco, R. J. & Van Dyke, T. E. Prevention: reducing the risk of CVD in patients with periodontitis. Nature Rev. Cardiol. 7, 479-480 (2010).
5. Lundberg, K., Wegner, N., Yucel-Lindberg, T. & Venables, P. J. Periodontitis in RA-the citrullinated enolase connection. Nature Rev. Rheumatol. 6, 727-730 (2010).
6. Kebschull, M., Demmer, R. T. & Papapanou, P. N. "Gum bug leave my heart alone": epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J. Dent. Res. 89, 879-902 (2010).
7. Whitmore, S. E. & Lamont, R. J. Oral bacteria and cancer. PLoS Pathog. 10, e1003933 (2014).
8. Han, Y. W. & Wang, X. Mobile microbiome: oral bacteria in extra-oral infections and inflammation. J. Dent. Res. 92, 485-491 (2013).
9. Madianos, P. N., Bobetsis, Y. A. & Offenbacher, S. Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms. J. Clin. Periodontol. 40, S170-S180 (2013).
10. Socransky, S. S. & Haffajee, A. D. Periodontal microbial ecology. Periodontol. 200038, 135-187 (2005).
11. Abusleme, L. et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J. 7, 1016-1025 (2013).
12. Griffen, A. L. et al. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 6, 1176-1185 (2012).
13. Jorth, P. et al. Metatranscriptomics of the human oral microbiome during health and disease. MBio 5, e01012-e01014 (2014).
14. Dewhirst, F. E. et al. The human oral microbiome. J. Bacteriol. 192, 5002-5017 (2010).
15. Hajishengallis, G. et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10, 497-506 (2011).
16. Hajishengallis, G., Darveau, R. P. & Curtis, M. A. The keystone-pathogen hypothesis. Nature Rev. Microbiol. 10, 717-725 (2012).
17. Darveau, R. P. Periodontitis: a polymicrobial disruption of host homeostasis. Nature Rev. Microbiol. 8, 481-490 (2010).
18. Rosier, B. T., de Jager, M., Zaura, E. & Krom, B. P. Historical and contemporary hypotheses on the development of oral diseases: are we there yet? Front Cell Infect. Microbiol. 4, 92 (2014).
19. Hajishengallis, G. & Lamont, R. J. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol. Oral Microbiol. 27, 409-419 (2012).
20. Hajishengallis, G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol. 35, 3-11 (2014).
21. Han, Y. W. et al. Term stillbirth caused by oral Fusobacterium nucleatum. Obstet. Gynecol. 115, 442-445 (2010).
22. Heo, S. M., Haase, E. M., Lesse, A. J., Gill, S. R. & Scannapieco, F. A. Genetic relationships between respiratory pathogens isolated from dental plaque and bronchoalveolar lavage fluid from patients in the intensive care unit undergoing mechanical ventilation. Clin. Infect. Dis. 47, 1562-1570 (2008).
23. Scannapieco, F. A. Individuals with chronic obstructive pulmonary disease (COPD) may be more likely to have more severe periodontal disease than individuals without COPD. J. Evid. Based Dent. Pract. 14, 79-81 (2014).
24. Tan, L., Wang, H., Li, C. & Pan, Y. 16S rDNA-based metagenomic analysis of dental plaque and lung bacteria in patients with severe acute exacerbations of chronic obstructive pulmonary disease. J. Periodont. Res. 49, 760-769 (2014).
25. Kozarov, E. V., Dorn, B. R., Shelburne, C. E., Dunn, W. A. Jr & Progulske-Fox, A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler. Thromb. Vasc. Biol. 25, e17-e18 (2005).
26. Haraszthy, V. I., Zambon, J. J., Trevisan, M., Zeid, M. & Genco, R. J. Identification of periodontal pathogens in atheromatous plaques. J. Periodontol. 71, 1554-1560 (2000).
27. Carrion, J. et al. Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential. J. Immunol. 189, 3178-3187 (2012).
28. Velsko, I. M. et al. Active invasion of oral and aortic tissues by Porphyromonas gingivalis in mice causally links periodontitis and atherosclerosis. PLoS ONE 9, e97811 (2014).
29. Slocum, C. et al. Distinct lipid A moieties contribute to pathogen-induced site-specific vascular inflammation. PLoS Pathog. 10, e1004215 (2014).
30. Maresz, K. J. et al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog. 9, e1003627 (2013).
31. Wegner, N. et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheumatol. 62, 2662-2672 (2010).
32. Mikuls, T. R. et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol. 66, 1090-1100 (2014).
33. Koziel, J., Mydel, P. & Potempa, J. The link between periodontal disease and rheumatoid arthritis: an updated review. Curr. Rheumatol. Rep. 16, 408 (2014).
34. Perez-Chaparro, P. J. et al. Newly identified pathogens associated with periodontitis: a systematic review. J. Dent. Res. 93, 846-858 (2014).
35. Sima, C. & Glogauer, M. Neutrophil dysfunction and host susceptibility to periodontal inflammation: current state of knowledge. Curr. Oral Health Rep. 1, 95-103 (2014).
36. Nussbaum, G. & Shapira, L. How has neutrophil research improved our understanding of periodontal pathogenesis? J. Clin. Periodontol. 38, 49-59 (2011).
37. Yilmaz, O. The chronicles of Porphyromonas gingivalis: the microbium, the human oral epithelium and their interplay. Microbiology 154, 2897-2903 (2008).
38. Darveau, R. P. Porphyromonas gingivalis neutrophil manipulation: risk factor for periodontitis? Trends Microbiol. 22, 428-429 (2014).
39. Bostanci, N. & Belibasakis, G. N. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS Microbiol. Lett. 333, 1-9 (2012).
40. Holt, S. C., Ebersole, J., Felton, J., Brunsvold, M. & Kornman, K. S. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 239, 55-57 (1988).
41. Darveau, R. P., Hajishengallis, G. & Curtis, M. A. Porphyromonas gingivalis as a potential community activist for disease. J. Dent. Res. 91, 816-820 (2012).
42. Maekawa, T. et al. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis. Cell Host Microbe 15, 768-778 (2014).
43. Hajishengallis, G. & Lamont, R. J. Breaking bad: manipulation of the host response by Porphyromonas gingivalis. Eur. J. Immunol. 44, 328-338 (2014).
44. Jiao, Y. et al. Induction of bone loss by pathobiont-mediated nod1 signaling in the oral cavity. Cell Host Microbe 13, 595-601 (2013).
45. Whitmore, S. E. & Lamont, R. J. The pathogenic persona of community-associated oral streptococci. Mol. Microbiol. 81, 305-314 (2011).
46. Haffajee, A. D. et al. Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects. J. Clin. Periodontol. 25, 346-353 (1998).
47. Kesavalu, L. et al. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect. Immun. 75, 1704-1712 (2007).
48. Daep, C. A., Novak, E. A., Lamont, R. J. & Demuth, D. R. Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii. Infect. Immun. 79, 67-74 (2011).
49. Orth, R. K., O'Brien-Simpson, N. M., Dashper, S. G. & Reynolds, E. C. Synergistic virulence of Porphyromonas gingivalis and Treponema denticola in a murine periodontitis model. Mol. Oral Microbiol. 26, 229-240 (2011).
50. Polak, D. et al. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response. J. Clin. Periodontol. 36, 406-410 (2009).
51. Tan, K. H. et al. Porphyromonas gingivalis and Treponema denticola exhibit metabolic symbioses. PLoS Pathog. 10, e1003955 (2014).
52. Amano, A. et al. Genetic characteristics and pathogenic mechanisms of periodontal pathogens. Adv. Dent. Res. 26, 15-22 (2014).
53. Kuboniwa, M. et al. Insights into the virulence of oral biofilms: discoveries from proteomics. Expert Rev. Proteom. 9, 311-323 (2012).
54. Cyktor, J. C. & Turner, J. Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens. Infect. Immun. 79, 2964-2973 (2011).
55. Hajishengallis, G. The inflammophilic character of the periodontitis-associated microbiota. Mol. Oral Microbiol. 29, 248-257 (2014).
56. Hajishengallis, E. & Hajishengallis, G. Neutrophil homeostasis and periodontal health in children and adults. J. Dent. Res. 93, 231-237 (2014).
57. Moutsopoulos, N. M. et al. Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss. Sci. Transl. Med. 6, 229ra240 (2014).
58. Ryder, M. I. Comparison of neutrophil functions in aggressive and chronic periodontitis. Periodontol. 200053, 124-137 (2010).
59. Chapple, I. L. & Matthews, J. B. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol. 200043, 160-232 (2007).
60. Eskan, M. A. et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nature Immunol. 13, 465-473 (2012).
61. Lee, W., Aitken, S., Sodek, J. & McCulloch, C. A. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J. Periodon. Res. 30, 23-33 (1995).
62. Hernandez, M. et al. Associations between matrix metalloproteinase-8 and-14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study. J. Periodontol. 81, 1644-1652 (2010).
63. Landzberg, M., Doering, H., Aboodi, G. M., Tenenbaum, H. C. & Glogauer, M. Quantifying oral inflammatory load: oral neutrophil counts in periodontal health and disease. J. Periodont. Res. http://dx.doi.org/10.1111/jre.12211 (2014).
64. Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J. D. Complement: a key system for immune surveillance and homeostasis. Nature Immunol. 11, 785-797 (2010).
65. Popadiak, K., Potempa, J., Riesbeck, K. & Blom, A. M. Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J. Immunol. 178, 7242-7250 (2007).
66. Jusko, M. et al. A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system. J. Immunol. 188, 2338-2349 (2012).
67. Potempa, M. et al. Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3. PLoS Pathog. 5, e1000316 (2009).
68. Miller, D. P. et al. Structure of factor H-binding protein B (FhbB) of the periopathogen, Treponema denticola: insights into progression of periodontal disease. J. Biol. Chem. 287, 12715-12722 (2012).
69. Malm, S. et al. Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia. PLoS ONE 7, e34852 (2012).
70. Liang, S. et al. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J. Immunol. 186, 869-877 (2011).
71. Burns, E., Bachrach, G., Shapira, L. & Nussbaum, G. Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J. Immunol. 177, 8296-8300 (2006).
72. Myneni, S. R. et al. TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. J. Immunol. 187, 501-509 (2011).
73. Shin, J. E., Baek, K. J., Choi, Y. S. & Choi, Y. A periodontal pathogen Treponema denticola hijacks the Fusobacterium nucleatum-driven host response. Immunol. Cell Biol. 91, 503-510 (2013).
74. Wang, M. et al. Microbial hijacking of complement-toll-like receptor crosstalk. Sci. Signal. 3, ra11 (2010).
75. Taxman, D. J. et al. Porphyromonas gingivalis mediates inflammasome repression in polymicrobial cultures through a novel mechanism involving reduced endocytosis. J. Biol. Chem. 287, 32791-32799 (2012).
76. Lamkanfi, M. & Dixit, V. M. Mechanisms and functions of inflammasomes. Cell 157, 1013-1022 (2014).
77. Moutsopoulos, N. M. et al. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J. Autoimmun. 39, 294-303 (2012).
78. Jauregui, C. E. et al. Suppression of T-cell chemokines by Porphyromonas gingivalis. Infect. Immun. 81, 2288-2295 (2013).
79. Hayashi, C. et al. Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen. J. Immunol. 189, 3681-3688 (2012).
80. Gemmell, E., Yamazaki, K. & Seymour, G. J. The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol. 200043, 14-40 (2007).
81. Gaffen, S. L. & Hajishengallis, G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J. Dent. Res. 87, 817-828 (2008).
82. Bahekar, A. A., Singh, S., Saha, S., Molnar, J. & Arora, R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am. Heart J. 154, 830-837 (2007).
83. Friedewald, V. E. et al. The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am. J. Cardiol. 104, 59-68 (2009).
84. Tonetti, M. S. et al. Treatment of periodontitis and endothelial function. N. Engl. J. Med. 356, 911-920 (2007).
85. Offenbacher, S. et al. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J. Periodontol. 80, 190-201 (2009).
86. Desvarieux, M. et al. Changes in clinical and microbiological periodontal profiles relate to progression of carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology study. J. Am. Heart Assoc. 2, e000254 (2013).
87. Brodala, N. et al. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb. Vasc. Biol. 25, 1446-1451 (2005).
88. Tonetti, M. S. Periodontitis and risk for atherosclerosis: an update on intervention trials. J. Clin. Periodontol. 36 (Suppl. 10), 15-19 (2009).
89. Arimatsu, K. et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci. Rep. 4, 4828 (2014).
90. Gibson, F. C. 3rd et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109, 2801-2806 (2004).
91. Jain, A. et al. Role for periodontitis in the progression of lipid deposition in an animal model. Infect. Immun. 71, 6012-6018 (2003).
92. Zelkha, S. A., Freilich, R. W. & Amar, S. Periodontal innate immune mechanisms relevant to atherosclerosis and obesity. Periodontol. 200054, 207-221 (2010).
93. Chiu, B. Multiple infections in carotid atherosclerotic plaques. Am. Heart J. 138, S534-S536 (1999).
94. Reyes, L., Herrera, D., Kozarov, E., Roldan, S. & Progulske-Fox, A. Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology. J. Clin. Periodontol. 40 (Suppl. 14), 30-50 (2013).
95. Hayashi, C. et al. Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses. J. Innate Immun. 2, 334-343 (2010).
96. Coats, S. R. et al. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1-and 4?-phosphatase activities. Cell. Microbiol. 11, 1587-1599 (2009).
97. Curtis, M. A. et al. Temperature dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defences. Infect. Immun. 79, 1187-1193 (2011).
98. Al-Qutub, M. N. et al. Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide. Infect. Immun. 74, 4474-4485 (2006).
99. Zenobia, C. et al. Porphyromonas gingivalis lipid A phosphatase activity is critical for colonization and increasing the commensal load in the rabbit ligature model. Infect. Immun. 82, 650-659 (2014).
100. Coats, S. R., Do, C. T., Karimi-Naser, L. M., Braham, P. H. & Darveau, R. P. Antagonistic lipopolysaccharides block E. coli lipopolysaccharide function at human TLR4 via interaction with the human MD-2 lipopolysaccharide binding site. Cell. Microbiol. 9, 1191-1202 (2007).
101. Bostanci, N. et al. Porphyromonas gingivalis antagonises Campylobacter rectus induced cytokine production by human monocytes. Cytokine 39, 147-156 (2007).
102. Wang, M. et al. Fimbrial proteins of Porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J. Immunol. 179, 2349-2358 (2007).
103. Wang, M. & Hajishengallis, G. Lipid raft-dependent uptake, signalling and intracellular fate of Porphyromonas gingivalis in mouse macrophages. Cell. Microbiol. 10, 2029-2042 (2008).
104. Manes, S., del Real, G. & Martinez, A. C. Pathogens: raft hijackers. Nature Rev. Immunol. 3, 557-568 (2003).
105. Zeituni, A. E., McCaig, W., Scisci, E., Thanassi, D. G. & Cutler, C. W. The native 67-kilodalton minor fimbria of Porphyromonas gingivalis is a novel glycoprotein with DC-SIGN-targeting motifs. J. Bacteriol. 192, 4103-4110 (2010).
106. Zeituni, A. E., Jotwani, R., Carrion, J. & Cutler, C. W. Targeting of DC-SIGN on human dendritic cells by minor fimbriated Porphyromonas gingivalis strains elicits a distinct effector T cell response. J. Immunol. 183, 5694-5704 (2009).
107. Miles, B. et al. Secondary lymphoid organ homing phenotype of human myeloid dendritic cells disrupted by an intracellular oral pathogen. Infect. Immun. 82, 101-111 (2014).
108. Liang, Z. et al. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 65, 967-971 (2005).
109. Sainz, J. & Sata, M. CXCR4, a key modulator of vascular progenitor cells. Arterioscler. Thromb. Vasc. Biol. 27, 263-265 (2007).
110. Belstrom, D. et al. The atherogenic bacterium Porphyromonas gingivalis evades circulating phagocytes by adhering to erythrocytes. Infect. Immun. 79, 1559-1565 (2011).
111. Madrigal, A. G., Barth, K., Papadopoulos, G. & Genco, C. A. Pathogen-mediated proteolysis of the cell death regulator RIPK1 and the host defense modulator RIPK2 in human aortic endothelial cells. PLoS Pathog. 8, e1002723 (2012).
112. Huck, O., Elkaim, R., Davideau, J. L. & Tenenbaum, H. Porphyromonas gingivalis-impaired innate immune response via NLRP3 proteolysis in endothelial cells. Innate Immun. 21, 65-72 (2014).
113. Harokopakis, E., Albzreh, M. H., Martin, M. H. & Hajishengallis, G. TLR2 transmodulates monocyte adhesion and transmigration via Rac1-and PI3K-mediated inside-out signaling in response to Porphyromonas gingivalis fimbriae. J. Immunol. 176, 7645-7656 (2006).
114. Takahashi, Y. et al. Fimbria-dependent activation of pro-inflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells. Cell. Microbiol. 8, 738-757 (2006).
115. Jain, S., Coats, S. R., Chang, A. M. & Darveau, R. P. A novel class of lipoprotein lipase-sensitive molecules mediates Toll-like receptor 2 activation by Porphyromonas gingivalis. Infect. Immun. 81, 1277-1286 (2013).
116. Clark, R. B. et al. Serine lipids of Porphyromonas gingivalis are human and mouse Toll-like receptor 2 ligands. Infect. Immun. 81, 3479-3489 (2013).
117. Delbosc, S. et al. Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation. Proof of concept in rats. PLoS ONE 6, e18679 (2011).
118. Nakayama, K. Porphyromonas gingivalis cell-induced hemagglutination and platelet aggregation. Periodontol. 200054, 45-52 (2010).
119. Han, Y. W., Houcken, W., Loos, B. G., Schenkein, H. A. & Tezal, M. Periodontal disease, atherosclerosis, adverse pregnancy outcomes, and head-and-neck cancer. Adv. Dent. Res. 26, 47-55 (2014).
120. Chen, Y. W. et al. Association between periodontitis and anti-cardiolipin antibodies in Buerger disease. J. Clin. Periodontol. 36, 830-835 (2009).
121. Li, X. Y. et al. Porphyromonas gingivalis lipopolysaccharide increases lipid accumulation by affecting CD36 and ATP-binding cassette transporter A1 in macrophages. Oncol. Rep. 30, 1329-1336 (2013).
122. Giacona, M. B. et al. Porphyromonas gingivalis induces its uptake by human macrophages and promotes foam cell formation in vitro. FEMS Microbiol. Lett. 241, 95-101 (2004).
123. Sanz, M. & Kornman, K. Periodontitis and adverse pregnancy outcomes: consensus report of the Joint EFP/AAP workshop on periodontitis and systemic diseases. J. Clin. Periodontol. 40 (Suppl. 14), 164-169 (2013).
124. Liu, H., Redline, R. W. & Han, Y. W. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response. J. Immunol. 179, 2501-2508 (2007).
125. Han, Y. W. et al. Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect. Immun. 72, 2272-2279 (2004).
126. Schenkein, H. A. et al. Anti-cardiolipin antibodies in sera from patients with periodontitis. J. Dent. Res. 82, 919-922 (2003).
127. Schenkein, H. A., Bradley, J. L. & Purkall, D. B. Anticardiolipin in Porphyromonas gingivalis antisera causes fetal loss in mice. J. Dent. Res. 92, 814-818 (2013).
128. Scher, J. U., Bretz, W. A. & Abramson, S. B. Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors? Curr. Opin. Rheumatol. 26, 424-429 (2014).
129. Joseph, R., Rajappan, S., Nath, S. G. & Paul, B. J. Association between chronic periodontitis and rheumatoid arthritis: a hospital-based case-control study. Rheumatol. Int. 33, 103-109 (2013).
130. de Pablo, P., Dietrich, T. & McAlindon, T. E. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J. Rheumatol. 35, 70-76 (2008).
131. Suwannalai, P., Trouw, L. A., Toes, R. E. & Huizinga, T. W. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Mod. Rheumatol. 22, 15-20 (2012).
132. Gyorgy, B., Toth, E., Tarcsa, E., Falus, A. & Buzas, E. I. Citrullination: a posttranslational modification in health and disease. Int. J. Biochem. Cell Biol. 38, 1662-1677 (2006).
133. Pyrc, K. et al. Inactivation of epidermal growth factor by Porphyromonas gingivalis as a potential mechanism for periodontal tissue damage. Infect. Immun. 81, 55-64 (2013).
134. Pratesi, F. et al. HLA shared epitope and ACPA: just a marker or an active player? Autoimmun. Rev. 12, 1182-1187 (2013).
135. Lundberg, K. et al. Antibodies to citrullinated α-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 58, 3009-3019 (2008).
136. Catrina, A. I., Ytterberg, A. J., Reynisdottir, G., Malmstrom, V. & Klareskog, L. Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis. Nature Rev. Rheumatol. (2014).
137. Sokolove, J. et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 7, e35296 (2012).
138. Gully, N. et al. Porphyromonas gingivalis peptidylarginine deiminase, a key contributor in the pathogenesis of experimental periodontal disease and experimental arthritis. PLoS ONE 9, e100838 (2014).
139. Paju, S. & Scannapieco, F. A. Oral biofilms, periodontitis, and pulmonary infections. Oral Dis. 13, 508-512 (2007).
140. Finegold, S. M. Aspiration pneumonia. Rev. Infect. Dis. 13, S737-S742 (1991).
141. Awano, S. et al. Oral health and mortality risk from pneumonia in the elderly. J. Dent. Res. 87, 334-339 (2008).
142. Kimizuka, R., Kato, T., Ishihara, K. & Okuda, K. Mixed infections with Porphyromonas gingivalis and Treponema denticola cause excessive inflammatory responses in a mouse pneumonia model compared with monoinfections. Microbes Infect. 5, 1357-1362 (2003).
143. Müller, F. Oral hygiene reduces the mortality from aspiration pneumonia in frail elders. J. Dent. Res. http://dx.doi.org/10.1177/0022034514552494 (2014).
144. Iinuma, T. et al. Denture wearing during sleep doubles the risk of pneumonia in the very elderly. J. Dent. Res. http://dx.doi.org/10.1177/0022034514552493 (2014).
145. Peter, K. P. et al. Association between periodontal disease and chronic obstructive pulmonary disease: a reality or just a dogma? J. Periodontol. 84, 1717-1723 (2013).
146. Sethi, S. & Murphy, T. F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 359, 2355-2365 (2008).
147. Pan, Y., Teng, D., Burke, A. C., Haase, E. M. & Scannapieco, F. A. Oral bacteria modulate invasion and induction of apoptosis in HEp-2 cells by Pseudomonas aeruginosa. Microb. Pathog. 46, 73-79 (2009).
148. Li, Q. et al. Porphyromonas gingivalis modulates Pseudomonas aeruginosa-induced apoptosis of respiratory epithelial cells through the STAT3 signaling pathway. Microbes Infect. 16, 17-27 (2014).
149. Yao, L. et al. Porphyromonas gingivalis infection sequesters pro-apoptotic BAD through AKT in primary gingival epithelial cells. Mol. Oral Microbiol. 25, 89-101 (2010).
150. Cannon, C. L., Kowalski, M. P., Stopak, K. S. & Pier, G. B. Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. Am. J. Respir. Cell. Mol. Biol. 29, 188-197 (2003).
151. Papapanou, P. N. in Oral Microbiology and Immunology (eds Lamont, R. J., Hajishengallis, G. & Jenkinson, H.) 251-271 (ASM Press, 2014).
152. Kumar, P. S. Smoking and the subgingival ecosystem: a pathogen-enriched community. Future Microbiol. 7, 917-919 (2012).
153. Stabholz, A., Soskolne, W. A. & Shapira, L. Genetic and environmental risk factors for chronic periodontitis and aggressive periodontitis. Periodontol. 200053, 138-153 (2010).
154. Laine, M. L., Crielaard, W. & Loos, B. G. Genetic susceptibility to periodontitis. Periodontol. 200058, 37-68 (2012).
155. Divaris, K. et al. Exploring the genetic basis of chronic periodontitis: a genome-wide association study. Hum. Mol. Genet. 22, 2312-2324 (2013).
156. Bagaitkar, J. et al. Tobacco smoke augments Porphyromonas gingivalis-Streptococcus gordonii biofilm formation. PLoS ONE 6, e27386 (2011).
157. Atanasova, K. R. & Yilmaz, O. Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association. Mol. Oral Microbiol. 29, 55-66 (2014).
158. Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299-306 (2012).
159. Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195-206 (2013).
160. Nagy, K. N., Sonkodi, I., Szoke, I., Nagy, E. & Newman, H. N. The microflora associated with human oral carcinomas. Oral Oncol. 34, 304-308 (1998).
161. Katz, J., Onate, M. D., Pauley, K. M., Bhattacharyya, I. & Cha, S. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int. J. Oral Sci. 3, 209-215 (2011).
162. Ahn, J., Segers, S. & Hayes, R. B. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis 33, 1055-1058 (2012).
163. Michaud, D. S. et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut 62, 1764-1770 (2013).
164. Inaba, H. et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell. Microbiol. 16, 131-145 (2014).
165. Kuboniwa, M. et al. P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes Infect. 10, 122-128 (2008).
166. Mao, S. et al. Intrinsic apoptotic pathways of gingival epithelial cells modulated by Porphyromonas gingivalis. Cell. Microbiol. 9, 1997-2007 (2007).
167. Yilmaz, O. et al. ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis. Cell. Microbiol. 10, 863-875 (2008).
168. Iwahori, K. et al. Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma. Int. J. Cancer 129, 993-1005 (2011).
169. Moffatt, C. E. & Lamont, R. J. Porphyromonas gingivalis induction of microRNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells. Infect. Immun. 79, 2632-2637 (2011).
170. Groeger, S., Domann, E., Gonzales, J. R., Chakraborty, T. & Meyle, J. B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis. Immunobiology 216, 1302-1310 (2011).
171. Sznol, M. & Chen, L. Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer. Clin. Cancer Res. 19, 1021-1034 (2013).